Free Trial

Retractable Technologies (RVP) Competitors

Retractable Technologies logo
$0.59 0.00 (0.00%)
(As of 11/20/2024 ET)

RVP vs. MGRM, NSPR, TMDIF, LUCD, HSAQ, NVNO, APYX, CTSO, DXR, and ICAD

Should you be buying Retractable Technologies stock or one of its competitors? The main competitors of Retractable Technologies include Monogram Orthopaedics (MGRM), InspireMD (NSPR), Titan Medical (TMDIF), Lucid Diagnostics (LUCD), Health Sciences Acquisitions Co. 2 (HSAQ), enVVeno Medical (NVNO), Apyx Medical (APYX), Cytosorbents (CTSO), Daxor (DXR), and iCAD (ICAD). These companies are all part of the "surgical & medical instruments" industry.

Retractable Technologies vs.

Monogram Orthopaedics (NASDAQ:MGRM) and Retractable Technologies (NYSE:RVP) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, valuation, analyst recommendations, community ranking, media sentiment and dividends.

Monogram Orthopaedics and Retractable Technologies both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Monogram OrthopaedicsN/AN/A
Retractable TechnologiesOutperform Votes
No Votes
Underperform Votes
73
100.00%

0.4% of Monogram Orthopaedics shares are held by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are held by institutional investors. 28.1% of Monogram Orthopaedics shares are held by company insiders. Comparatively, 54.6% of Retractable Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Monogram Orthopaedics has a beta of 2.28, meaning that its stock price is 128% more volatile than the S&P 500. Comparatively, Retractable Technologies has a beta of 2.06, meaning that its stock price is 106% more volatile than the S&P 500.

Monogram Orthopaedics has a net margin of 0.00% compared to Retractable Technologies' net margin of -41.11%. Retractable Technologies' return on equity of -17.15% beat Monogram Orthopaedics' return on equity.

Company Net Margins Return on Equity Return on Assets
Monogram OrthopaedicsN/A -130.90% -106.38%
Retractable Technologies -41.11%-17.15%-9.33%

Retractable Technologies has higher revenue and earnings than Monogram Orthopaedics. Monogram Orthopaedics is trading at a lower price-to-earnings ratio than Retractable Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Monogram Orthopaedics$365.00K188.01-$13.74M-$0.47-4.26
Retractable Technologies$43.60M0.40-$7.01M-$0.54-1.09

In the previous week, Retractable Technologies had 1 more articles in the media than Monogram Orthopaedics. MarketBeat recorded 4 mentions for Retractable Technologies and 3 mentions for Monogram Orthopaedics. Monogram Orthopaedics' average media sentiment score of 0.28 beat Retractable Technologies' score of 0.25 indicating that Monogram Orthopaedics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Monogram Orthopaedics
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Retractable Technologies
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Retractable Technologies beats Monogram Orthopaedics on 8 of the 13 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RVP vs. The Competition

MetricRetractable TechnologiesSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$17.55M$4.41B$5.04B$19.88B
Dividend YieldN/A41.16%5.16%3.52%
P/E Ratio-1.0924.83130.5342.95
Price / Sales0.4047.021,183.8619.18
Price / Cash35.7551.8733.6117.86
Price / Book0.184.974.685.52
Net Income-$7.01M$13.76M$119.23M$986.45M
7 Day Performance-7.60%-1.08%-1.83%0.45%
1 Month Performance-23.12%0.58%-3.61%1.05%
1 Year Performance-46.70%50.91%31.74%24.67%

Retractable Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RVP
Retractable Technologies
N/A$0.59
flat
N/A-45.9%$17.51M$43.60M-1.09148Analyst Forecast
MGRM
Monogram Orthopaedics
1.094 of 5 stars
$2.00
-2.0%
N/A-38.8%$70.00M$364,999.00-4.2628
NSPR
InspireMD
2.5564 of 5 stars
$2.67
+3.9%
$4.50
+68.5%
-4.0%$69.64M$6.82M-3.5650Analyst Forecast
TMDIF
Titan Medical
N/A$0.60
flat
N/A+769.6%$68.73M$17.63M12.004
LUCD
Lucid Diagnostics
3.2198 of 5 stars
$1.00
+4.2%
$3.69
+268.8%
-23.1%$59.34M$4.19M-0.8870High Trading Volume
HSAQ
Health Sciences Acquisitions Co. 2
N/A$5.28
+2.1%
N/A-23.3%$59.20MN/A0.004
NVNO
enVVeno Medical
0.6699 of 5 stars
$3.37
-6.6%
N/A-13.8%$59.11MN/A-2.6119News Coverage
High Trading Volume
APYX
Apyx Medical
1.4466 of 5 stars
$1.40
+9.4%
N/A-39.1%$52.70M$48.54M-1.58270
CTSO
Cytosorbents
1.2772 of 5 stars
$0.92
-4.2%
$2.00
+118.4%
-34.6%$52.47M$33.79M-2.54186Analyst Forecast
Gap Down
DXR
Daxor
N/A$9.03
+0.4%
$24.75
+174.1%
+14.4%$43.71MN/A0.00N/AHigh Trading Volume
ICAD
iCAD
0.526 of 5 stars
$1.55
-1.3%
N/A+16.2%$41.40M$18.94M-11.8867Analyst Upgrade
High Trading Volume

Related Companies and Tools


This page (NYSE:RVP) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners